EGFR and glioblastoma: Epidermal growth factor receptor (EGFR) and it’s variant, EGFRvIII, are well-established therapeutic targets in glioblastoma100 expressed in 40–60% of glioblastoma tumors101 and minimal expression on surrounding tissue102.